| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Burford Capital (NYSE:BUR) reported quarterly earnings of $2.74 per share which beat the analyst consensus estimate of $2.17 by...
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
The Ross School of Business at the University of Michigan hosted the expanded Maize and Blue Stock Pitch Competition on Feb.
Burford Capital announces the pricing of its private offering of $275.0 million aggregate principal amount of additional 9.250%...
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an ac...
U.S. stock futures were slightly lower this morning, with the Dow Jones futures falling around 5 points on Wednesday.
U.S. stock futures traded mostly lower this morning, with the Dow Jones futures falling around 50 points on Tuesday.
Wedbush analyst David Chiaverini maintains Burford Capital (NYSE:BUR) with a Outperform and lowers the price target from $20...
